laboratory biomarker analysis [clinicaltrials_resource:5b31390aac23b9eac16b773d0b5e5031]
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [clinicaltrials:NCT00017472]Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00026143]Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer [clinicaltrials:NCT00033462]Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00039117]Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [clinicaltrials:NCT00047190]Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors [clinicaltrials:NCT00053352]Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [clinicaltrials:NCT00055770]Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00064324]Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers [clinicaltrials:NCT00074308]Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors [clinicaltrials:NCT00074321]Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [clinicaltrials:NCT00075439]Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma [clinicaltrials:NCT00075634]Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia [clinicaltrials:NCT00077467]CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00079235]Sorafenib in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00096434]clinicaltrials:NCT00107536clinicaltrials:NCT00233948Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer [clinicaltrials:NCT00343109]clinicaltrials:NCT00357448Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia [clinicaltrials:NCT00360776]Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma [clinicaltrials:NCT00363272]clinicaltrials:NCT00398112VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer [clinicaltrials:NCT00407654]Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery [clinicaltrials:NCT00407888]Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease After Donor Stem Cell Transplant [clinicaltrials:NCT00408681]Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma [clinicaltrials:NCT00410605]clinicaltrials:NCT00425672clinicaltrials:NCT00509249Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor [clinicaltrials:NCT00638898]Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery [clinicaltrials:NCT00645710]Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00673153]Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast Cancer [clinicaltrials:NCT00679029]Bowman-Birk Inhibitor Concentrate in Healthy Men [clinicaltrials:NCT00679094]Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer [clinicaltrials:NCT00691730]clinicaltrials:NCT00720135Resveratrol in Healthy Adult Participants [clinicaltrials:NCT00721877]Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment [clinicaltrials:NCT00845104]clinicaltrials:NCT00859937Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate [clinicaltrials:NCT00898404]MUC1 Vaccine for Triple-negative Breast Cancer [clinicaltrials:NCT00986609]
intervention [clinicaltrials_vocabulary:intervention]
laboratory biomarker analysis [clinicaltrials_resource:5b31390aac23b9eac16b773d0b5e5031]
Bio2RDF identifier
5b31390aac23b9eac16b773d0b5e5031
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5b31390aac23b9eac16b773d0b5e5031
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Correlative studies
intervention name [clinicaltrials_vocabulary:intervention-name]
laboratory biomarker analysis
identifier
clinicaltrials_resource:5b31390aac23b9eac16b773d0b5e5031
title
laboratory biomarker analysis
@en
type
label
laboratory biomarker analysis [clinicaltrials_resource:5b31390aac23b9eac16b773d0b5e5031]
@en